Gensyn: Product Launch
Gensyn launched Delphi, an AI-powered decentralized information market platform targeting the $250 billion creator economy. This is a significant product launch into a new market segment.
Source: PR Newswire - Financial Services
The leadership read
Product momentum tends to widen the sector product and commercial leadership bench strength.
Market context: the MitchelLake Talent Market Index reads 114.6 — Hot (+16.3 vs prior month); Americas signal share is steady (-1.3pts).
MitchelLake in this thematic
Our work · 2020
Chief Technology Officer
Splitit
Americas · Fintech · payments · fintech
Our work · 2020
Senior Product Manager
Yanka Industries Inc. (Masterclass)
Americas · Sport, Media & Entertainment · product · edtech
Our work · 2019
Director of Product
Tubi, Inc.
Americas · Sport, Media & Entertainment · product · streaming
More signals across Americas
Product Launch · Americas
SevenRooms →SevenRooms launched Channel Connect on June 16, 2026 - a free tool that automatically syncs reservation data from multiple restaurant platforms, solving multi-platform management challenges for hospitality venues.
Product Launch · Americas
Orchid →Vancouver-based AI startup Orchid launched a free World Cup experience allowing fans to receive live scores, match information, and local guidance through text messaging. This consumer-facing launch demonstrates the broader AI personal assistant platform capabilities for real-time experiences beyond workplace productivity.
Product Launch · Americas
Electronic Arts (EA) →EA launched its first advertising platform enabling brands to purchase in-game ad placements (stadium boards, scoreboards) across FC, Madden, and College Football titles, representing a new monetization and partnership channel.
Product Launch · Americas
Genesis →Genesis revealed the Magma GT3 Concept car at Le Mans 24 Hours, signalling entry into GT3 racing category following Mercedes and Toyota
Product Launch · Americas
Vertex Pharmaceuticals →Vertex Pharmaceuticals reported Phase 3 data for ALYFTREK showing improved CF function in children ages 2-5, and TRIKAFTA showing benefits in children ages 1-2. Company advanced nephrology pipeline with FDA acceptance of Biologics License Application for povetacicept in IgA nephropathy.
Product Launch · Americas
Abridge →Abridge unveiled an AI-native clinician intelligence platform that transitions from passive documentation to active end-to-end clinical intelligence spanning pre-visit, intra-visit, and real-time billing. Enterprise-wide rollout announced at Northwestern Medicine with NVIDIA partnership for custom foundation model.